MONARCH 2 Trial - Patient Characteristics and OS Results

Classes Oncology MONARCH 2 Trial - Patient Characteristics and OS Results

Instructions

Please Sign in to your account to see the Class.

Introduction

In this short video, Dr. Meteb Al Foheidi from the Department of Oncology at King Saud Bin Abdulaziz University for Health Science – NGHA, Jeddah, and the Chairman of Board of Directors of Saudi Oncology Society along with Dr. Mark Verrill from Northern Center for Cancer Care at Freeman Hospital, UK discuss the Monarch 2 HR+, HER2- MBC patients’ characteristics and the OS results.